Download PDF
Journal of Pediatric Neurology 2020; 18(06): 273-278
DOI: 10.1055/s-0040-1715500
Review Article

Transition to Adulthood for Pediatric Moyamoya Patients

R Michael Scott
1   Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
,
Edward R. Smith
1   Department of Neurosurgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Moyamoya is a progressive arteriopathy of the intracranial vasculature, predominantly affecting the terminal branches of the internal carotid artery. Treatment is predicated on surgical revascularization to reduce the risk of stroke. For patients diagnosed and treated as children, it is important to recognize the long-term implications of the disease, for example, that moyamoya is treatable, but not curable. Pediatric moyamoya patients face unique challenges as they transition to adulthood as a consequence of the chronic nature of this disorder. Successful long-term care requires a strategy that incorporates ongoing longitudinal disease monitoring, coordination of care between physician teams, and anticipation of socioeconomic factors that change over time. This article provides an approach to transition care to adult caregivers for pediatric moyamoya patients with a specific focus on the three key stakeholders in the process: the neurosurgeon, the primary care physician, and the individual patient.

Keywords

moyamoya - pediatric - adult - transition - cerebrovascular - stroke


Publication History

Received: 20 December 2018

Accepted: 29 March 2019

Article published online:
20 August 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Stuttgart · New York

 

  • References

  • 1 Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009; 360 (12) 1226-1237
    CrossrefPubMedGoogle Scholar
  • 2 Ganesan V, Smith ER. Moyamoya: defining current knowledge gaps. Dev Med Child Neurol 2015; 57 (09) 786-787
    CrossrefPubMedGoogle Scholar
  • 3 Smith ER, Scott RM. Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. J Neurosurg Pediatr 2012; 9 (04) 353-360
    CrossrefPubMedGoogle Scholar
  • 4 Storey A, Michael Scott R, Robertson R, Smith E. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease. J Neurosurg Pediatr 2017; 19 (03) 289-295
    CrossrefPubMedGoogle Scholar
  • 5 Macyszyn L, Attiah M, Ma TS. et al. Direct versus indirect revascularization procedures for moyamoya disease: a comparative effectiveness study. J Neurosurg 2017; 126 (05) 1523-1529
    CrossrefPubMedGoogle Scholar
  • 6 Titsworth WL, Scott RM, Smith ER. National analysis of 2454 pediatric moyamoya admissions and the effect of hospital volume on outcomes. stroke 2016; 47 (05) 1303-1311
    CrossrefPubMedGoogle Scholar
  • 7 Rothstein DH, Li V. Transitional care in pediatric neurosurgical patients. Semin Pediatr Surg 2015; 24 (02) 79-82
    CrossrefPubMedGoogle Scholar
  • 8 Fujiwara H, Momoshima S, Kuribayashi S. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease. Eur J Radiol 2005; 55 (02) 224-230
    CrossrefPubMedGoogle Scholar
  • 9 Kawashima M, Noguchi T, Takase Y, Nakahara Y, Matsushima T. Decrease in leptomeningeal ivy sign on fluid-attenuated inversion recovery images after cerebral revascularization in patients with moyamoya disease. AJNR Am J Neuroradiol 2010; 31 (09) 1713-1718
    CrossrefPubMedGoogle Scholar
  • 10 Lee JK, Yoon BH, Chung SY, Park MS, Kim SM, Lee DS. The usefulness of the ivy sign on fluid-attenuated intensity recovery images in improved brain hemodynamic changes after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease. J Korean Neurosurg Soc 2013; 54 (04) 302-308
    CrossrefPubMedGoogle Scholar
  • 11 Yoon H-K, Shin H-J, Chang YW. “Ivy sign” in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images. Radiology 2002; 223 (02) 384-389
    CrossrefPubMedGoogle Scholar
  • 12 Kawaguchi S, Sakaki T, Morimoto T, Kakizaki T, Kamada K. Characteristics of intracranial aneurysms associated with moyamoya disease. A review of 111 cases. Acta Neurochir (Wien) 1996; 138 (11) 1287-1294
    CrossrefPubMedGoogle Scholar
  • 13 Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y. Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 2005; 36 (10) 2148-2153
    CrossrefPubMedGoogle Scholar
  • 14 Lee JY, Choi Y-H, Cheon J-E. et al. Delayed posterior circulation insufficiency in pediatric moyamoya disease. J Neurol 2014; 261 (12) 2305-2313
    CrossrefPubMedGoogle Scholar
  • 15 Lee JY, Kim SK, Cheon JE. et al. Posterior cerebral artery involvement in moyamoya disease: initial infarction and angle between PCA and basilar artery. Childs Nerv Syst 2013; 29 (12) 2263-2269
    CrossrefPubMedGoogle Scholar
  • 16 Perry LD, Robertson F, Ganesan V. Screening for cerebrovascular disease in microcephalic osteodysplastic primordial dwarfism type II (MOPD II): an evidence-based proposal. Pediatr Neurol 2013; 48 (04) 294-298
    CrossrefPubMedGoogle Scholar
  • 17 Smith ER, Scott RM. Progression of disease in unilateral moyamoya syndrome. Neurosurg Focus 2008; 24 (02) E17
    CrossrefPubMedGoogle Scholar
  • 18 Yang S, Yu JL, Wang HL, Wang B, Luo Q. Endovascular embolization of distal anterior choroidal artery aneurysms associated with moyamoya disease. A report of two cases and a literature review. Interv Neuroradiol 2010; 16 (04) 433-441
    CrossrefPubMedGoogle Scholar
  • 19 Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. J Neurosurg Pediatr 2013; 11 (04) 417-425
    CrossrefPubMedGoogle Scholar
  • 20 Singla A, Lin N, Ho AL, Scott RM, Smith ER. Vascular collateralization along ventriculoperitoneal shunt catheters in moyamoya disease. J Neurosurg Pediatr 2013; 11 (06) 710-712
    CrossrefPubMedGoogle Scholar
  • 21 Lin N, Aronson JP, Manjila S, Smith ER, Scott RM. Treatment of moyamoya disease in the adult population with pial synangiosis. J Neurosurg 2014; 120 (03) 612-617
    CrossrefPubMedGoogle Scholar
  • 22 Plu-Bureau G, Sabbagh E, Hugon-Rodin J. [Hormonal contraception and vascular risk: CNGOF contraception guidelines]. Gynécol Obstét Fertil Sénol 2018; 46 (12) 823-833
    CrossrefPubMedGoogle Scholar
  • 23 Maragkos GA, Ascanio LC, Chida K. et al. Moyamoya disease in pregnancy: a systematic review. Acta Neurochir (Wien) 2018; 160 (09) 1711-1719
    CrossrefPubMedGoogle Scholar
  • 24 Inayama Y, Kondoh E, Chigusa Y. et al. Moyamoya disease in pregnancy: a 20-year single-center experience and literature review. World Neurosurg 2019; 122: 684-691.e2
    CrossrefPubMedGoogle Scholar
  • 25 Jung YJ, Kim M-A, Kwon J-Y. et al. Pregnancy outcomes in women with moyamoya disease: experiences at a single center in Korea. Yonsei Med J 2015; 56 (03) 793-797
    CrossrefPubMedGoogle Scholar
  • 26 Kamada F, Aoki Y, Narisawa A. et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet 2011; 56 (01) 34-40
    CrossrefPubMedGoogle Scholar
  • 27 Liu W, Morito D, Takashima S. et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011; 6 (07) e22542
    CrossrefPubMedGoogle Scholar
  • 28 Gaillard J, Klein J, Duran D. et al. Incidence, clinical features, and treatment of familial moyamoya in pediatric patients: a single-institution series. J Neurosurg Pediatr 2017; 19 (05) 553-559
    CrossrefPubMedGoogle Scholar
  • 29 Smith ER. Moyamoya biomarkers. J Korean Neurosurg Soc 2015; 57 (06) 415-421
    CrossrefPubMedGoogle Scholar
  • 30 Gross BA, Du R. The natural history of moyamoya in a North American adult cohort. J Clin Neurosci 2013; 20 (01) 44-48
    CrossrefPubMedGoogle Scholar
  • 31 Zhao M, Deng X, Gao F. et al. Ischemic stroke in young adults with moyamoya disease: prognostic factors for stroke recurrence and functional outcome after revascularization. World Neurosurg 2017; 103: 161-167
    CrossrefPubMedGoogle Scholar
  • 32 Unger MD, Georges J, Shaikh HA, Kavi T. Moyamoya tipping point: fatal bilateral MCA territory infarction following cocaine abuse. BMJ Case Rep 2018; 2018: bcr-2017
    PubMedGoogle Scholar
  • 33 Ohkawa S, Tabuchi M, Yamadori A. [A case of moyamoya-like disease with repetitive TIA on drinking]. Rinsho Shinkeigaku 1992; 32 (07) 758-762
    PubMedGoogle Scholar
  • 34 Lyoo CH, Kim DJ, Chang H, Lee MS. Moyamoya disease presenting with paroxysmal exercise-induced dyskinesia. Parkinsonism Relat Disord 2007; 13 (07) 446-448
    CrossrefPubMedGoogle Scholar
  • 35 Singhal NS, Hills NK, Sidney S, Fullerton HJ. Role of trauma and infection in childhood hemorrhagic stroke due to vascular lesions. Neurology 2013; 81 (06) 581-584
    CrossrefPubMedGoogle Scholar